Icon

INDERAL LA (nda018553)- (60MG,80MG,120MG,160MG)

PROPRANOLOL HYDROCHLORIDE ANI PHARMS
60MG,80MG,120MG,160MG
Yes No
Expired Expired
None None
None No
Propranolol hydrochloride extended-release capsules are indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Propranolol hydrochloride extended-release capsules is not indicated in the management of hypertensive emergencies. Propranolol hydrochloride extended-release capsules are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. Propranolol hydrochloride extended-release capsules are indicated for the prophylaxis of common migraine headache. Propranolol hydrochloride extended-release capsules improve NYHA functional class in symptomatic patients with hypertrophic subaortic stenosis.
6 0 5
Total Other Developers 18
Drugs with Suitability No
60MG ** ** - - 3
80MG ** ** - - 3
120MG ** ** - - 3
160MG ** ** - - 3
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** *** ***** ***** *** **********, ***. *********** ** ***** ****, ******, *** ****** (**) *****, ****** ****** (***) ***
****** ******* ********* ******* ********* *** *********** *** ****** ***, *********, *** ****** (**) *****, ****** ****** (***) ***
****** ***** ****** *** ***** ***************, ***. *********** *** ****** **., ********, **** (**) *****-****, ****** ****** (***) ***
****** ***** ****** *** *** ***** ************ ******* *********** ****** **. ***, *** *** ***, ******* ***** *. *. **. ** *******-*******, ******-****** *********, *********, ******* ******, ***** (***) ***
****** **** ******* ********* **** ***** ****** ***** *********** **. ***, ******* ****, *******, ***** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.